A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2011
11/02/2011	CN102228614A Formula and method for preparing traditional Chinese medicine for treating heart meridian tissue disease
11/02/2011	CN102228605A Deficiency and dryness improving ultra-micro powder as well as production method and application thereof to preparation of medicament for preventing and treating climacteric hypertension
11/02/2011	CN102228596A Pharmaceutical composition and preparation and applications thereof in treating coronary heart disease and angina pectoris
11/02/2011	CN102228575A Medicament for external use for treating hypertension, and production method thereof
11/02/2011	CN102228542A Traditional Chinese medicine preparation for treating stroke
11/02/2011	CN102228539A Rosa davurica total flavone extract, its extracting method and its medical use
11/02/2011	CN102228535A Application of total saponins and total flavones in preparation of drugs for treating cardiovascular diseases
11/02/2011	CN102228534A Method for extracting flavone from hawthorn berry
11/02/2011	CN102228525A Traditional Chinese medicine for treating cardio-cerebral vascular stagnation
11/02/2011	CN102228519A Application of extract of Rheum emodi Wall. in preparing medicine for controlling ischemic heart disease (IHD)
11/02/2011	CN102228515A Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
11/02/2011	CN102228511A Soft capsule for treating cardiovascular diseases and preparation method thereof
11/02/2011	CN102228510A Ginkgo biloba-ginseng vein relaxing capsule and preparation method thereof
11/02/2011	CN102228508A Method for preparing compound salvia miltiorrhiza tablets
11/02/2011	CN102228507A Method for extracting engelhardtia roxburghiana extract and engelhardtia roxburghiana extract capsules thereof
11/02/2011	CN102228506A Composition of malaytea scurfpea extract as well as preparation method and use thereof
11/02/2011	CN102228500A Method for producing Euonymus hederaceus Champ. ex Benth preparation and application thereof
11/02/2011	CN102228498A Preparation method and application of total flavonoids in stem leaves of chrysanthemum
11/02/2011	CN102228496A Medicine for treating hypertension
11/02/2011	CN102228495A Preparation method of injection for treating cardio-cerebral vascular diseases
11/02/2011	CN102228493A Medicine for treating coronary heart disease
11/02/2011	CN102228472A Reagent for causing targeting effect of marrow mesenchymal stem cells on myocardial infarction focus, and its preparation method
11/02/2011	CN102228457A Pharmaceutical composition for treating diabetes and complication thereof
11/02/2011	CN102228456A Novel * ketone compound and its protection effect on nerve cell
11/02/2011	CN102228454A Brain targeting via olfactory pathway fragrant essential oil compound and monomer pharmaceutical composition with functions for preventing and treating brain atrophy and activating brain cells
11/02/2011	CN102228450A Nicergoline capsule and production method thereof
11/02/2011	CN102228446A Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof
11/02/2011	CN102228443A Clevidipine butyrate microspheres and preparation method thereof
11/02/2011	CN102228436A Slow-release liquid crystal nanoparticle containing vinpocetine prepared by supercritical fluid method
11/02/2011	CN102228434A Clevidipine butyrate emulsion, preparation method thereof and purpose thereof
11/02/2011	CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof
11/02/2011	CN102228427A Vitexin glucoside injection and preparation method thereof
11/02/2011	CN102228252A Application of Chinese medicinal composition in preparation of healthcare foods and medicines for improving hypoxia tolerance
11/02/2011	CN102228179A Fructose sodium diphosphate oral solution and preparation method thereof
11/02/2011	CN102048692B Aerosol containing Breviscapine and preparation method thereof
11/02/2011	CN101837101B Traditional Chinese medicine anther cap for controlling cardiovascular and cerebrovascular diseases, preparing method and quality control method thereof
11/02/2011	CN101732492B Adinandra nitida leaf flavone oral tablet and preparation method
11/02/2011	CN101732387B Detection method of Naoan capsules
11/02/2011	CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof
11/02/2011	CN101549017B Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof
11/02/2011	CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof
11/02/2011	CN101230090B Blood peptide X and derivative thereof as well as preparation method and use thereof
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048991 Antibody to an integrin heterodimer and/or a subunit thereof
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048452 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
11/01/2011	US8048441 Nanobead releasing medical devices
11/01/2011	US8048407 In situ gelling self-reactive materials for embolization
11/01/2011	CA2641473C Condensed imidazole derivatives as aldosterone synthase inhibitors
11/01/2011	CA2596283C Embolization using poly-4-hydroxybutyrate particles
11/01/2011	CA2535749C Ppar activating compound and pharmaceutical composition containing same
11/01/2011	CA2493208C Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/01/2011	CA2492060C Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
11/01/2011	CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011	CA2488834C Purine derivatives and their use as antiproliferative agents
11/01/2011	CA2476683C Partial and full agonists of a1 adenosine receptors
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011	CA2468254C Therapeutic coating for an intravascular implant
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2374916C Diagnostics and therapeutics for cardiovascular disorders
10/2011
10/27/2011	WO2011133966A2 Method and compositions for treating ace2-related disorders
10/27/2011	WO2011133875A2 Metalloenzyme inhibitor compounds
10/27/2011	WO2011133855A1 Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
10/27/2011	WO2011133841A2 Intravenous omega-3 fatty acid compositions & method of use
10/27/2011	WO2011133750A1 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	WO2011132171A1 Nitric oxide releasing prodrugs of therapeutic agents
10/27/2011	WO2011132048A1 Heteroaryl compounds as pde10a inhibitors
10/27/2011	WO2011131613A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011086306A9 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases
10/27/2011	WO2011066182A3 Socs3 inhibition promotes cns neuron regeneration
10/27/2011	WO2011056985A3 Substituted heterocyclic compounds
10/27/2011	WO2011056511A3 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
10/27/2011	WO2011046392A3 Composition for improving blood circulation and alleviating cold hands and feet, containing fermented tea extract
10/27/2011	WO2002023190A8 Methods and products related to low molecular weight heparin
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263718 Process for the preparation of o-desmethylvenlafaxine
10/27/2011	US20110263711 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
10/27/2011	US20110263702 Methods and Compositions for Improved Chromium Complexes
10/27/2011	US20110263687 Rna molecules and uses thereof
10/27/2011	US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011	US20110263680 Reduced size self-delivering rnai compounds
10/27/2011	US20110263674 C-nitroso-derived nitroxyl donors
10/27/2011	US20110263673 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives
10/27/2011	US20110263669 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors
10/27/2011	US20110263668 Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure
10/27/2011	US20110263667 Salts of isobutyric acid (1 r,2r,4r*) -2- (2- - ethyl)-5-phenyl-bicyclo [2.2.2] oct-5-en-2-yl
10/27/2011	US20110263666 process for the preparation or purification of olmesartan medoxomil
10/27/2011	US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011	US20110263660 Antihypertensive pharmaceutical composition
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263658 Renin inhibitors
10/27/2011	US20110263657 Diaryl ureas for treating heart failure

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1595